Form 8-K - Current report:
SEC Accession No. 0001640334-18-002208
Filing Date
2018-11-15
Accepted
2018-11-15 17:14:17
Documents
5
Period of Report
2018-11-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 10728
2 EX_99.1 lxrp_ex991.htm EX-99.1 9715
3 lxrp_8kimg1.jpg GRAPHIC 159431
4 lxrp_8kimg2.jpg GRAPHIC 3158
5 lxrp_8kimg3.jpg GRAPHIC 2975
  Complete submission text file 0001640334-18-002208.txt   250069
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 181187999
SIC: 1000 Metal Mining